Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2019 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2019 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy

  • Authors:
    • Yiran Wang
    • Yueqi Chen
    • Xuedan Chen
    • Yan Liang
    • Dapeng Yang
    • Jiao Dong
    • Neng Yang
    • Zhiqing Liang
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China, Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China, Department of Medical Genetics, College of Basic Medical Science, Third Military Medical University, Chongqing 400038, P.R. China, Department of Respiratory Medicine, The General Hospital of PLA Rocket Force, Beijing 100088, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3365-3374
    |
    Published online on: September 6, 2019
       https://doi.org/10.3892/etm.2019.7985
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Angelicin is an active compound isolated from the Chinese herb Angelica archangelica, which has been reported to exert antitumor effects by inhibiting malignant behaviors in several types of tumor, including proliferation, colony formation, migration and invasion. However, the effects of angelicin on human cervical cancer cells is yet to be elucidated. The present study evaluated the antitumor effects of angelicin on cervical cancer cells. The results demonstrated that cervical cancer cells were more sensitive to angelicin than cervical epithelial cells. At its IC30, angelicin inhibited the proliferation of HeLa and SiHa cells by blocking the cell cycle at the G1/G0 phase and inhibiting other malignant behaviors, including colony formation, tumor formation in soft agar, migration and invasion. At the IC50, angelicin induced cell death potentially by promoting apoptosis. By identifying the hallmarks of autophagy, it was observed that angelicin treatment caused the accumulation of microtubule associated protein 1 light chain 3‑β (LC3B) in the cytoplasm of HeLa and SiHa cells. Western blotting results demonstrated that cleaved LC3B‑II and autophagy related proteins (Atg)3, Atg7 and Atg12‑5 were upregulated following angelicin treatment. It was also determined that the phosphorylation of mTOR was induced by angelicin treatment. Furthermore, the inhibition of angelicin‑induced mTOR phosphorylation did not disrupt its inhibitory effect on autophagy, indicating that angelicin inhibited autophagy in an mTOR‑independent manner. Taken together, the present results suggested that angelicin regulated malignant behaviors in cervical cancer cells by inhibiting autophagy in an mTOR‑independent manner. Findings suggested that autophagy might be a potential therapeutic target for cervical cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Burger H, Loos WJ, Eechoute K, Verweij J, Mathijssen RH and Wiemer EA: Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resist Updat. 14:22–34. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Lilic V, Lilic G, Filipovic S, Milosevic J, Tasic M and Stojiljkovic M: Modern treatment of invasive carcinoma of the uterine cervix. J BUON. 14:587–592. 2009.PubMed/NCBI

4 

Rodríguez Villalba S, Díaz-CanejaPlanell C and Cervera Grau JM: Current opinion in cervix carcinoma. Clin Transl Oncol. 13:378–384. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Tsai JH, Hsu LS, Huang HC, Lin CL, Pan MH, Hong HM and Chen WJ: 1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione induces g1 cell cycle arrest and autophagy in HeLa cervical cancer cells. Int J Mol Sci. 17:E12742016. View Article : Google Scholar : PubMed/NCBI

6 

Li N and Zhang W: Protein kinase C β inhibits autophagy and sensitizes cervical cancer HeLa cells to cisplatin. Biosci Rep. 37:BSR201604452017. View Article : Google Scholar : PubMed/NCBI

7 

Kavli G, Midelfart K, Raa J and Volden G: Phototoxicity from furocoumarins (psoralens) of Heracleum laciniatum in a patient with vitiligo. Action spectrum studies on bergapten, pimpinellin, angelicin and sphondin. Contact Dermatitis. 9:364–336. 1983. View Article : Google Scholar : PubMed/NCBI

8 

Lampronti I, Bianchi N, Borgatti M, Fibach E, Prus E and Gambari R: Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin. Eur J Haematol. 71:189–195. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Mira A and Shimizu K: In vitro cytotoxic activities and molecular mechanisms of angelica shikokiana extract and its isolated compounds. Pharmacogn Mag. 11 (Suppl 4):S564–S569. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Wang F, Li J, Li R, Pan G, Bai M and Huang Q: Angelicin inhibits liver cancer growth in vitro and in vivo. Mol Med Rep. 16:5441–5449. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Fang W, Shu S, Yongmei L, Endong Z, Lirong Y and Bei S: miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200. Sci Rep. 6:332292016. View Article : Google Scholar : PubMed/NCBI

12 

Spanò V, Parrino B, Carbone A, Montalbano A, Salvador A, Brun P, Vedaldi D, Diana P, Cirrincione G and Barraja P: Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer. Eur J Med Chem. 102:334–351. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Bruni R, Barreca D, Protti M, Brighenti V, Righetti L, Anceschi L, Mercolini L, Benvenuti S, Gattuso G and Pellati F: Botanical sources, chemistry, analysis, and biological activity of furanocoumarins of pharmaceutical interest. Molecules. 24:E21632019. View Article : Google Scholar : PubMed/NCBI

14 

Colter DC, Class R, DiGirolamo CM and Prockop DJ: Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 97:3213–3218. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Hu L, Sun S, Wang T, Li Y, Jiang K, Lin G, Ma Y, Barr MP, Song F, Zhang G and Meng S: Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy. Am J Cancer Res. 5:3612–3623. 2015.PubMed/NCBI

16 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Trout JJ, Stauber WT and Schottelius BA: Increased autophagy in chloroquine-treated tonic and phasic muscles: An alternative view. Tissue Cell. 13:393–401. 1981. View Article : Google Scholar : PubMed/NCBI

18 

Yang Z and Klionsky DJ: Mammalian autophagy: Core molecular machinery and signaling regulation. CurrOpin Cell Biol. 22:124–131. 2010.

19 

Feng Y, He D, Yao Z and Klionsky DJ: The machinery of macroautophagy. Cell Res. 24:24–41. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Tooze SA and Yoshimori T: The origin of the autophagosomal membrane. Nat Cell Biol. 12:831–835. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Adem J, Ropponen A, Eeva J, Eray M, Nuutinen U and Pelkonen J: Differential expression of Bcl-2 family proteins determines the sensitivity of human follicular lymphoma cells to dexamethasone-mediated and anti-BCR-mediated apoptosis. J Immunother. 39:8–14. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Chen TC, Yu MC, Chien CC, Wu MS, Lee YC and Chen YC: Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation. Toxicol In Vitro. 31:1–11. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Hsieh MJ, Chen MK, Yu YY, Sheu GT and Chiou HL: Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines. Phytomedicine. 21:970–977. 2014. View Article : Google Scholar : PubMed/NCBI

24 

D'Anqiolillo F, Pistellia L, Noccioli C, Ruffoni B, Piaqqi S, Scarpato R and Pistelli L: In vitro cultures of Bituminariabituminosa: Pterocarpan, furanocoumarin and isoflavone production and cytotoxic activity evaluation. Nat Prod Commun. 9:477–480. 2014.PubMed/NCBI

25 

Li M, Gao P and Zhang J: Crosstalk between autophagy and apoptosis: Potential and emerging therapeutic targets for cardiac diseases. Int J Mol Sci. 17:3322016. View Article : Google Scholar : PubMed/NCBI

26 

Kamada Y, Yoshino K, Kondo C, Kawamata T, Oshiro N, Yonezawa K and Ohsumi Y: Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol Cell Biol. 30:1049–1058. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Hara T and Mizushima N: Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy. 5:85–87. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Mizushima N: The role of the Atg1/ULK1 complex in autophagy regulation. CurrOpin Cell Biol. 22:132–139. 2010.

29 

Choi H, Merceron C, Mangiavini L, Seifert EL, Schipani E, Shapiro IM and Risbud MV: Hypoxia promotes noncanonical autophagy in nucleus pulposus cells independent of MTOR and HIF1A signaling. Autophagy. 12:1631–1646. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang Y, Chen Y, Chen X, Liang Y, Yang D, Dong J, Yang N and Liang Z: Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy. Exp Ther Med 18: 3365-3374, 2019.
APA
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J. ... Liang, Z. (2019). Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy. Experimental and Therapeutic Medicine, 18, 3365-3374. https://doi.org/10.3892/etm.2019.7985
MLA
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J., Yang, N., Liang, Z."Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy". Experimental and Therapeutic Medicine 18.5 (2019): 3365-3374.
Chicago
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J., Yang, N., Liang, Z."Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy". Experimental and Therapeutic Medicine 18, no. 5 (2019): 3365-3374. https://doi.org/10.3892/etm.2019.7985
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Chen Y, Chen X, Liang Y, Yang D, Dong J, Yang N and Liang Z: Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy. Exp Ther Med 18: 3365-3374, 2019.
APA
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J. ... Liang, Z. (2019). Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy. Experimental and Therapeutic Medicine, 18, 3365-3374. https://doi.org/10.3892/etm.2019.7985
MLA
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J., Yang, N., Liang, Z."Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy". Experimental and Therapeutic Medicine 18.5 (2019): 3365-3374.
Chicago
Wang, Y., Chen, Y., Chen, X., Liang, Y., Yang, D., Dong, J., Yang, N., Liang, Z."Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy". Experimental and Therapeutic Medicine 18, no. 5 (2019): 3365-3374. https://doi.org/10.3892/etm.2019.7985
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team